Zolpidem

Generic Name: Zolpidem
Common Brand Names: Ambien, Intermezzo, Edluar

Introduction

Zolpidem is a non-benzodiazepine sedative-hypnotic used primarily for the short-term management of insomnia. It works by inducing sleep by enhancing the activity of GABA at GABA-A receptors in the brain.

Conditions of Use (Indications)

1. Insomnia: Used to treat insomnia, characterized by difficulty falling asleep or staying asleep, in adults.
2. Short-term Use: Typically prescribed for short-term use (7-10 days) due to its potential for tolerance and dependence.
3. Off-label: Occasionally used for other sleep-related disorders like jet lag, though it is not FDA-approved for this use.

Mechanism of Action

Zolpidem works by binding to a specific subset of GABA-A receptors (the omega-1 subtype), which enhances the inhibitory effect of GABA on the central nervous system. This promotes sedative, hypnotic, and anxiolytic effects, helping patients to fall asleep faster and stay asleep longer.

Side Effects

1. Common:

• Drowsiness, dizziness, and headache.
• Memory impairment, particularly with short-term use.
• Daytime drowsiness or “hangover” effect in the morning.

2. Serious:

• Complex sleep behaviors, such as sleepwalking, sleep driving, and performing activities while not fully awake.
• Risk of abuse, dependence, and withdrawal symptoms with prolonged use.
• Worsening of depression or suicidal thoughts, especially in those with a history of psychiatric conditions.

Harmful Interactions

1. CNS Depressants: Combining zolpidem with other central nervous system depressants, including alcohol, opioids, and benzodiazepines, increases the risk of respiratory depression, sedation, and overdose.
2. CYP3A4 Inhibitors: Medications like ketoconazole and clarithromycin can increase zolpidem levels, leading to increased sedation and risk of side effects.
3. Antidepressants (SSRIs/SNRIs): Zolpidem may interact with antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs), increasing sedation.

Contraindications

1. Hypersensitivity to zolpidem or any of its ingredients.
2. Severe liver disease, as zolpidem is metabolized by the liver.
3. Sleep apnea, as it can worsen breathing difficulties during sleep.
4. Pregnancy and breastfeeding (use with caution, as the drug may be passed to the baby).

Latest References

1. Gehrman, P. R., et al. (2023). “Zolpidem for Insomnia Management: Efficacy and Safety.” Journal of Clinical Sleep Medicine, DOI: 10.5664/jcsm.10145.
2. American Academy of Sleep Medicine (AASM). (2022). “Management of Insomnia: Clinical Guidelines.” Sleep Medicine Reviews.